v" There is no direct information on the effect of calcium antagonists on intracerebral penetrating arterioles, which are responsible for a significant part of total cerebrovascular resistance. In a study on rats, the effects of four calcium antagonists (diltiazem, verapamil, nifedipine, and nimodipine) on isolated intracerebral penetrating arterioles with mean resting diameters (+ standard error of the mean) of 52.3 _+ 3.0 ~zm were investigated.
C ALCIUM channel blockers cause vasodilation by preventing the influx of extracellular calcium into vascular smooth-muscle cells. Clinical and experimental studies indicate that calcium antagonists are effective in the treatment of cerebral ischemia after subarachnoid hemorrhage (SAH). 1,7,1v,25 Much is known about the physiological contractile properties of cerebral arteries and pial surface arterioles. Extrapolation of these data to the level of the intracerebral microcirculation may not be justified. Longitudinal heterogeneity of responsiveness to vasoactive agonists in the cerebral circulation is well described, especially for adrenergic and serotonergic vasoconstrictors. 10.12 For example, norepinephrine, a potent constrictor of vascular smooth muscle in large arteries and arterioles in most peripheral vascular beds, has little effect on pial and intracerebral arterioles. ~2, 21 Similarly, it may be inappropriate to assume that calcium antagonists act on intracerebral vessels in the same way that they act on larger cerebral arteries. The objective of the present study was to examine the effects of calcium antagonists on intracerebral arterioles.
Methods have been developed for the study of isolated intracerebral or penetrating arterioles. 12-14 These techniques enable direct observations of the reactivity of viable penetrating arterioles while precisely controlling intra-and extraluminal fluid composition. In this paper, the potent and prolonged vasodilation effects of extraluminally applied calcium antagonists on the resting diameter of isolated intracerebral penetrating arterioles are reported.
Materials and Methods

Isolation and Cannulation of Vessels
Animal experimentation was conducted in conformity with the American Physiological Society's "Guiding Principles in the Care and Use of Animals." Methods Effect of calcium antagonists on arterioles for the isolation and cannulation techniques are described by Dacey, Briefly, penetrating cerebral arterioles, 20 to 80 t~m in diameter, were surgically isolated from the first (M1) portion of the middle cerebral artery of pentobarbital-anesthetized Sprague-Dawley rats weighing 300 to 400 gm. The vessel segments were transferred to a temperature-controlled chamber on the stage of a Nikon inverted microscope and were cannulated using glass pipettes. Vessel diameters and wall thickness were determined by means of a videodimensional analysis system.
After cannulation, transmural pressure was applied at 60 mm Hg via the cannulating pipette and the external solution was brought from room temperature to between 37* and 38"C. Over an equilibration period of approximately 45 minutes, during which time the bath solution was changed three to four times, spontaneous tone developed. Responsiveness of the vessels was then assessed by changing the extraluminal pH from 7.3 to 6.8 and from 7.3 to 7.6.
Perfusion and Bath Solutions
The physiological salt solutions (PSS's) used in this preparation were modified Ringer's solutions with a composition as follows (in mM): NaC1 144, KC1 3.0, CaC12 2.5, MgSO4 1.5, glucose 5, pyruvate 2, ethylenediaminetetra-acetic acid (EDTA) 0.02, 3-[N-morpholin] propanesulfonic acid 2.0 (MOPS), NaH2PO4 1.21, and bovine serum albumin 0.9 to 1 gm/100 ml. The intraluminal solution pH was maintained at 7.3 for all experiments. The extraluminal solution contained no albumin and the pH was varied from 6.8 to 7.6.
Dose-Response Curves of Calcium Antagonists
Control vessel diameter was defined as the diameter to which the vessels spontaneously contracted during the equilibration period in a bath solution of pH 7.3. Bath solutions of increasing concentrations of calcium antagonists were added sequentially to the cannulation chamber. The pH of each solution was measured prior to instillation into the chamber, and was found not to vary significantly from pH 7.3. The vessel diameter was allowed to stabilize over a period of 4 to 5 minutes between each change in bath solution. A control solvent-vehicle response experiment was carried out for nifedipine and nimodipine, which needed special solvent vehicles (ethanol and polyethylene glycol 400 (PEG), respectively).
Time Courses For Recovery From Dilation By Calcium Antagonists
To investigate the recovery time course from dilation effects of calcium antagonists, the following procedure was used for application and washout of all drugs. After a 5-minute exposure to the minimum dose of a drug that induced maximum dilation, the bath solution was changed three times, then once every 5 minutes thereafter. The course of change in vessel diameter over time was compared to that for adenosine, a well-known cerebral vasodilator. 8"28 The doses used for this study were as follows: diltiazem 10 -4 M, verapamil 10 -5 M, nifedipine 10 -6 M, nimodipine 10 -6 M, and adenosine 10 -3 M.
Drug Preparation
Care was taken to avoid light-inactivation of nifedipine and nimodipine. Diltiazem, verapamil, and adenosine were dissolved in PSS. Ethanol was the solvent for nifedipine (10 -3 M) and PEG for nimodipine ( 10 -3 M). Further dilutions (10 -5 to 10 -12 M) were made with PSS.
Statistical Analysis
Group mean diameters for each drug dose, expressed as a percentage of control vessel diameter, were first compared by one-way analysis of variance (ANOVA) and subsequently by Student-Newman-Keuls multiple range test. 3~ The level of significance was 0.05. Median effective dose (EDs0) values were calculated from probit transformations as described by Tallarida and Murray. 26 Negative log EDs0 values were used to calculate the relative potencies of the different antagonists. Values are given as means _ standard error of the means.
Results
The passive arteriolar diameter, as determined for each vessel at the beginning of the experimental protocol in an extraluminal bath solution of pH 7.3 at 60 mm Hg transmural pressure and 24"C, averaged 78.2 _ 4.3 um for 28 specimens. The control vessel diameter after development of spontaneous tone at 37"C averaged 52.3 _ 3.0 ttm. When the extraluminal pH was changed, vessels dilated to 138% _ 2.3% at pH 6.8 and constricted to 73.6% _ 1.1% at pH 7.6. Vessels that showed weak responses (< 20% dilation at pH 6.8 or < 15% contraction at pH 7.6) were discarded at this stage. Control diameters and pH responses were not significantly different among vessels used to determine doseresponse curves (Table 1) or recovery time courses (Table 2) . 
Dose.Response Curves to Calcium Antagonists
Calcium antagonists dilated penetrating arterioles immediately after their application, inducing m a x i m u m effects within 2 to 3 minutes at each dose. These dilation responses were dose-dependent and significant for every calcium antagonist (ANOVA: p < 0.001). M a x i m u m dilation for each calcium antagonist was as foUows: diltiazem 46.4% -+ 5.6%, verapamil 53.1% _+ 6.0%, nifedipine 46.9% -+ 6.1%, and nimodipine 47.1% + 5.4% (Fig. 1) . The magnitude of m a x i m u m dilation was not significantly different a m o n g these calcium antagonists (ANOVA: p = 0.845). Solvent vehicles had essentially no effect on the diameter of penetrating arterioles at concentrations corresponding to those used with nefidipine or nimodipine between 10 -12 and 10 -6 M (Fig. 1C and D) . Ethanol, however, significantly constricted the arterioles at the highest concentration, corresponding to 10 -5 M nifedipine (ANOVA: p < M. Takayasu, J. E. Bassett, and R. G. Dacey, Jr. 0.001). Nifedipine at 10 -s M constricted the vessels significantly when compared with 10 -6 M (p < 0.05), and this constriction was comparable to that obtained with the solvent alone (Fig. 1C ).
Sensitivity of penetrating arterioles to each calcium antagonist occurred in the following order: diltiazem 1.52 x t0 -6 M (-log EDso: 6.12 + 0.21 for six specimens), verapamil 1.08 x l0 -~ M (-log EDso: 7.01 +-0.09 for five specimens), nifedipine 8.65 x 10 -9 M (-log EDso: 8.10 + 0.09 for five specimens), and nimodipine 1.62 • 10 -9 M (-log EDso: 8.98 + 0.21 for seven specimens). These values were all significantly different from each other (p < 0.01).
Time Courses For Recovery From Dilation By Calcium Antagonists
Recovery time for dilation effects of calcium antagonists after washout, as compared with that of adeno- Solvents had essentially no effect on vessel diameter at concentrations corresponding to those used with nifedipine or nimodipine between 10 -t2 and 10 -6 M (C and D). Ethanol significantly constricted vessels only at the highest concentration corresponding to 10 -5 nifedipine (ANOVA: p < 0.00t). Nifedipine at 10 -5 M significantly constricted vessels when compared to 10 -6 M (p < 0.05), and this constriction was comparable to that obtained with the solvent alone (C). PEG = polyethylene glycol 400.
Effect of calcium antagonists on arterioles sine, is shown in Fig. 2 . Time for return to the resting diameter (100% _ 5%) with each drug was as follows: adenosine 8.5 + 1.0 minutes, diltiazem 15.5 + 1.8 minutes, verapamil 12.5 -1.8 minutes, nifedipine 19.0 +-3.9 minutes, and nimodipine 30.0 + 1.6 minutes. Recovery time was significantly longer with diltiazem (p < 0.05) and with nifedipine and nimodipine (p > 0.01) than with adenosine. Recovery time was also significantly longer with nimodipine than with the other calcium antagonists (p < 0.01).
Discussion
The present study demonstrates that four calcium antagonists (diltiazem, verapamil, nifedipine, and nimodipine) significantly dilate intracerebral penetrating arterioles. Dilation persists for a significantly longer time after washout with diltiazem, nifedipine, and nimodipine than with adenosine, while recovery time with verapamil was not significantly different from that with adenosine. This is the first direct examination of the effects of calcium antagonists on intracerebral penetrating arterioles, the most distal resistance vessels in the cerebral microcirculation.
Few in vitro studies of the effects of calcium antagonists on resting (nonactivated) diameter or tone have been done, except for pial arteriole studies using in vivo cranial window methods. In larger arteries, the effects of calcium antagonists have been studied by their anticontractile effects to various vasoconstrictors or their vasodilatory effects after precontraction by agonists. TM The magnitude of vasodilation in cranial window studies in vivo is reported most frequently to be less than 25%: 6% caused by 10 -4 M verapamil in rats, 4 15% by 10 -5 M verapamil and 6% by 1 0 -7 M nimodipine in mice, 23 and 21% by 10 -5 M nimodipine in cats. 6 One exceptional study in cats showed a 33% dilation caused by 6 x 10 -7 M nifedipine and a further dilation of about 80% by 10 -3 M nifedipine. 11 This study is the only one that used the microinjection technique for the application of drugs. In our study of penetrating arterioles in rats, the magnitude of vasodilation was about 50% for each calcium antagonist.
The duration of vasodilation of pial arterioles b y calcium antagonists was also investigated in cats by Auer and M o k r y . 6 They found that vessel diameters returned to 5 % above resting levels within 15 minutes after superfusion of 2.4 x 10 -5 M nimodipine for 10 minutes. T h e vessels in our study took 30 minutes to return to 5 % above resting diameter after washout of as little as 1 0 -6 M nimodipine applied for 5 minutes. Recovery time seems to depend on the concentration and duration of application of calcium antagonists. In the present study, after cumulative long-term applications of calcium antagonists, recovery times approaching 1 hour were necessary for the arterioles to return to resting diameter. Recovery time also depends on the calcium antagonists involved: nimodipine had the most prolonged effect of the four calcium antagonists studied, and diltiazem and nifedipine had effects of longer duration than adenosine. These differences in recovery time m a y be due to a different affinity to receptor sites, and could also be related to lipid solubility, because lipid-soluble drugs such as nifedipine and nimodipine had longer recovery times than water-soluble drugs such as diltiazem and verapamil.
There are significant interspecies differences in the responsiveness of cerebral arteries to calcium antago-FIG. 2. Time courses after washout for recovery from dilation by calcium antagonists compared with that of adenosine. The minimum dose of each drug sufficient to induce maximum dilation was used. Time for return to resting diameter (100% + 5%: mean +_ standard error of the mean) was significantly longer with diltiazem (A) (p < 0.05), nifedipine (C), and nimodipine (D) (p < 0.01) than with adenosine. Recovery time was also significantly longer with nimodipine than with the calcium antagonists (p < 0.01). 22 have shown that nimodipine causes varying degrees of vasodilation when applied to the basilar artery of dog, monkey, and man. Caution should also be used in extrapolating from in vitro vascular preparation data to mechanisms of cerebral blood flow control in the intact human. Nonetheless, the present data suggest that, at least in rats, calcium antagonists cause dilation of intracerebral arterioles of greater amplitude and duration than that seen in pial arterioles. Several characteristic differences are noted in intracerebral penetrating arterioles as compared with the other vessels in the cerebral circulation. First, the penetrating arterioles have smaller vessel diameters, usually less than 100 #m. Second, morphologically, the wall consists of only one layer of smoothmuscle cells and a thin adventitial layer of leptomeningeal sheath, with a layer of endothelial cells.13 Third, neuropharmacological differences are noted. Sympathetic innervation of the smaller intraparenchymal vessels is thought to be associated with a catecholamine system arising in the locus ceruleus, while the larger cerebral vessels are innervated by nerves arising in the superior cervical ganglion.18 Heterogeneity in the distribution of perivascular neuropeptides in cerebral vessels has recently been reported. 15,~6 Immunoreactivity to neuropeptide Y was particularly abundant around the major arteries of the circle of Willis, and could be readily demonstrated in pial arterioles on the convexity of the cerebral cortex, but was noted only occasionally around penetrating arterioles. 16 The reason for the more pronounced effect of calcium antagonists on the penetrating arterioles is not clear. One possible explanation might be that penetrating arterioles have smaller diameters, given the fact that dilation responses to calcium antagonists become significantly greater with decreasing arteriolar size in pial arterioles. 6"7'11 Morii, et aL, 2~ reported that 10 -3 M adenosine produced an almost twofold increase in the diameter of rat pial arterioles, which appears to be greater than the dilation seen with penetrating arterioles in our study (about 40% increase in diameter by 10 -3 M adenosine). It seems unlikely, therefore, that greater vasodilation of penetrating arterioles by calcium antagonists would simply be the result of their higher basal tone compared to that of pial arterioles. Alternatively, the tone of penetrating arterioles might be more dependent on extracellular calcium.
In our experiments with penetrating arterioles, a 60% dilation was produced by calcium-free media containing 0.5 mM EDTA. The vessels rapidly returned to their control diameter, usually within 3 minutes after the bath solution was changed to calcium-containing media (unpublished data from our laboratory). Thus, the long-lasting effects of calcium antagonists on penetrating arterioles may be due to their higher affinity to receptor sites of penetrating arterioles than to those of pial arterioles, and may not be due to failure to reestablish intracellular calcium pools once they are depleted.
Our data suggest that the spontaneous tone of intra-cerebral arterioles is highly dependent on extracellular calcium. This appears to be different from the myogenic tone of larger cerebral arteries, which was independent of extracellular calcium in studies conducted with diltiazem by Bevan. 9 The ED~o'S of intracerebral penetrating arterioles in response to the four calcium antagonists were 1.52 x l0 -6 M (diltiazem), 1.08 x 10 -7 M (verapamil), 8 .65 x l0 -9 M (nifedipine), and 1.62 • 10 -9 M (nimodipine). These values are quite similar to those found in larger cerebral arteries. 24"27 Ethanol, a solvent for nifedipine, significantly constricted penetrating arterioles at a concentration corresponding to 10 -5 M nifedipine (22%). It is likely that the vasoconstriction observed at 10 -5 M nifedipine is due to the effect of the solvent. Our result with ethanol is comparable to that found by Altura, et aL, 3 in larger cerebral arteries and pial arterioles, although a higher dose was required to constrict those vessels; in our study 10 -4 M nifedipine could not eliminate the constriction by ethanol.
Various calcium antagonists have recently become available for the treatment of cerebral arterial vasospasm, which is an important cause of morbidity and mortality in patients with SAH. 1' 2"25 Clinical studies increasingly suggest that calcium antagonists do exert a beneficial effect on the overall course of the sequelae of SAH. ~' 5 Despite these encouraging results, recent clinical and laboratory evidence suggests that systemic therapy with calcium antagonists may not significantly affect the degree of angiographicaUy visualized vasospasm. 1"17' 19' 29 For example, Ljunggren, et al., 19 concluded that, in patients undergoing early surgery after SAH, neurological deficits due to spasm were lessened by nimodipine therapy, whereas the degree of angiographically defined vasospasm was unchanged. Our data may help to explain this apparent discrepancy between anglography and clinical findings in patients with cerebral vasospasm who are undergoing treatment with calcium antagonists. It appears that intracerebral arterioles are more sensitive to calcium antagonists than are angiographically visible larger cerebral arteries, and may be responsible for decreased total cerebrovascular resistance despite persistent contraction of more proximal vessels within the subarachnoid space. More data are needed before this information on relatively normal intracerebral arterioles can be extrapolated to arterioles affected by SAH.
